Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Main human AOD-9604 treatment timelines Study METAOD004 Participants 36 Route Oral Treatment length 7 days Dose range 9, 27, or 54 mg/day Main lesson Short safety and tolerability study Study METAOD005 Participants 300 Route Oral Treatment length 12 weeks Dose range 1 to 30 mg/day Main lesson Earlier weight-loss trial with a non-linear dose response Study METAOD006 Participants 502 randomized Route Oral Treatment length 24 weeks Dose range 0.25, 0.5, or 1 mg/day Main lesson Primary weight-loss goal was not met The oral milligram doses in these trials cannot be converted into subcutaneous microgram doses
It does not constitute personal medical advice and must not replace a formal consultation, diagnosis, or treatment plan from a qualified healthcare provider
Peptide therapy for women often includes tailored protocols that target symptoms of perimenopause and menopause, including fatigue, weight gain, and decreased libido
doi: 10.1161/CIR.0000000000001040 [PubMed] [CrossRef] [Google Scholar] Jepsen M.M
When combined, this peptide stack creates a comprehensive healing environment
